Killing and mutagenic actions of dacarbazine, a chemotherapeutic alkylating agent, on human and mouse cells: effects of Mgmt and Mlh1 mutations
- 1 April 2004
- journal article
- Published by Elsevier in DNA Repair
- Vol. 3 (4) , 413-420
- https://doi.org/10.1016/j.dnarep.2003.12.008
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 24 references indexed in Scilit:
- Roles of MGMT and MLH1 proteins in alkylation-induced apoptosis and mutagenesisDNA Repair, 2003
- Combined loss of expression of O6‐methylguanine‐DNA methyltransferase and hMLH1 accelerates progression of hepatocellular carcinomaJournal of Surgical Oncology, 2003
- Gene silencing in phenomena related to DNA repairOncogene, 2002
- Increased susceptibility to chemotherapeutic alkylating agents of mice deficient in DNA repair methyltransferaseCarcinogenesis: Integrative Cancer Research, 2000
- MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomasOncogene, 1998
- High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferaseCarcinogenesis: Integrative Cancer Research, 1997
- ACCELERATED PAPER: Targeted disruption of the DNA repair methyltransferase gene renders mice hypersensitive to alkylating agentCarcinogenesis: Integrative Cancer Research, 1996
- DNA-repair methyltransferase as a molecular device for preventing mutation and cancerZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Mouse methyltransferase for repair of O6-methylguanine and O4-methylthymine in DNACarcinogenesis: Integrative Cancer Research, 1995
- Organization and expression of the human gene for O6-methylguanine-DNA methyltransferaseMutation Research/DNA Repair, 1993